Enjoy complimentary customisation on priority with our Enterprise License!
The insulin syringes market size is forecast to increase by USD 388 million at a CAGR of 4.5% between 2023 and 2028. The market is experiencing significant growth due to the rising global burden of diabetes, with an estimated 463 million adults living with the condition in 2019. The market is further driven by increasing awareness programs for diabetes, which highlight the importance of proper insulin administration. However, non-adherence to insulin regimens remains a major challenge, leading to complications and increased healthcare costs. To address this issue, innovative insulin delivery devices, such as insulin pens and continuous glucose monitoring systems, are gaining popularity. Additionally, advancements in insulin formulations and needle technologies are improving patient comfort and reducing the fear of injections. These factors, coupled with government initiatives and collaborations between industry players and healthcare providers, are expected to drive market growth in the coming years.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.